Los Angeles Capital Management
BEAM icon

Los Angeles Capital Management’s Beam Therapeutics BEAM Stock Holding History

Los Angeles Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.7K Hold
449
– – ﹤0.01% 1938
2025
Q4 		$10.7K Buy
+449
New +$11.5K ﹤0.01% 2055
2024
Q3 		– Sell
-16,787
Closed -$393K – 1176
2024
Q2 		$393K Sell
16,787
-1,105
-6% -$27.1K ﹤0.01% 928
2024
Q1 		$591K Hold
17,892
– – ﹤0.01% 824
2023
Q4 		$487K Sell
17,892
-6,873
-28% -$171K ﹤0.01% 876
2023
Q3 		$596K Sell
24,765
-2,084
-8% -$55.9K ﹤0.01% 779
2023
Q2 		$857K Buy
26,849
+4,301
+19% +$140K ﹤0.01% 685
2023
Q1 		$690K Sell
22,548
-2,410
-10% -$95.1K ﹤0.01% 765
2022
Q4 		$976K Buy
24,958
+7,601
+44% +$340K ﹤0.01% 717
2022
Q3 		$827K Buy
17,357
+861
+5% +$49.1K ﹤0.01% 765
2022
Q2 		$639K Buy
16,496
+4,199
+34% +$167K ﹤0.01% 873
2022
Q1 		$705K Buy
12,297
+4,200
+52% +$275K ﹤0.01% 900
2021
Q4 		$645K Sell
8,097
-106
-1% -$9.08K ﹤0.01% 891
2021
Q3 		$714K Hold
8,203
– – ﹤0.01% 894
2021
Q2 		$1.06M Sell
8,203
-220
-3% -$17.5K ﹤0.01% 829
2021
Q1 		$674K Buy
+8,423
New +$801K ﹤0.01% 1084

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Los Angeles Capital Management's BEAM Position: Q1 2026 in Review

Los Angeles Capital Management held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 449 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1938.

Los Angeles Capital Management first reported a position in BEAM in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.06M in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Los Angeles Capital Management held 449 shares of Beam Therapeutics worth $10.7K as of Q1 2026.
  • Los Angeles Capital Management left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1938 holding.
  • Los Angeles Capital Management first reported a position in Beam Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Los Angeles Capital Management's Beam Therapeutics position peaked at $1.06M in Q2 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.